{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T22:28:31Z","timestamp":1793053711700,"version":"4.5.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["euoncology.europeanurology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology Oncology"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.euo.2023.12.002","type":"journal-article","created":{"date-parts":[[2023,12,28]],"date-time":"2023-12-28T08:29:34Z","timestamp":1703752174000},"page":"944-953","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Comparison of Regional Saturation Biopsy, Targeted Biopsy, and Systematic Biopsy in Patients with Prostate-specific Antigen Levels of 4\u201320 ng\/ml: A Prospective, Single-center, Randomized Controlled Trial"],"prefix":"10.1016","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3084-1655","authenticated-orcid":false,"given":"Xingkang","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingzhe","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohua","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ranlu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuanghe","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanjie","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euo.2023.12.002_b0005","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1056\/NEJMoa2209454","article-title":"Prostate cancer screening with PSA and MRI followed by targeted biopsy only","volume":"387","author":"Hugosson","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.euo.2023.12.002_b0010","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1056\/NEJMoa2100852","article-title":"MRI-targeted or standard biopsy in prostate cancer screening","volume":"385","author":"Eklund","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.euo.2023.12.002_b0015","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/s41585-022-00684-0","article-title":"Landmarks in the evolution of prostate biopsy","volume":"20","author":"Connor","year":"2023","journal-title":"Nat Rev Urol"},{"key":"10.1016\/j.euo.2023.12.002_b0020","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.eururo.2016.08.004","article-title":"Complications after systematic, random, and image-guided prostate biopsy","volume":"71","author":"Borghesi","year":"2017","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2023.12.002_b0025","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.eururo.2022.12.008","article-title":"Environmental impact of prostate magnetic resonance imaging and transrectal ultrasound guided prostate biopsy","volume":"83","author":"Leapman","year":"2023","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2023.12.002_b0030","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.eururo.2022.01.008","article-title":"Targeted prostate biopsy: umbra, penumbra, and value of perilesional sampling","volume":"82","author":"Brisbane","year":"2022","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2023.12.002_b0035","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.prnil.2023.01.003","article-title":"How many cores should be taken from each region of interest when performing a targeted transrectal prostate biopsy?","volume":"11","author":"Cetin","year":"2023","journal-title":"Prostate Int"},{"key":"10.1016\/j.euo.2023.12.002_b0040","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.euros.2022.04.001","article-title":"Diagnostic performance of a magnetic resonance imaging-directed targeted plus regional biopsy approach in prostate cancer diagnosis: a systematic review and meta-analysis","volume":"40","author":"Hagens","year":"2022","journal-title":"Eur Urol Open Sci"},{"key":"10.1016\/j.euo.2023.12.002_b0045","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/S1470-2045(18)30569-2","article-title":"Use of prostate systematic and targeted biopsy on the basis of multiparametric MRI in biopsy-naive patients (MRI-FIRST): a prospective, multicentre, paired diagnostic study","volume":"20","author":"Rouvi\u00e8re","year":"2019","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.euo.2023.12.002_b0050","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/s41585-019-0212-4","article-title":"Multiparametric MRI for prostate cancer diagnosis: current status and future directions","volume":"17","author":"Stabile","year":"2020","journal-title":"Nat Rev Urol"},{"key":"10.1016\/j.euo.2023.12.002_b0055","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.eururo.2018.11.023","volume":"75","author":"van der Leest","year":"2019","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2023.12.002_b0060","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.euo.2020.02.005","article-title":"Factors influencing variability in the performance of multiparametric magnetic resonance imaging in detecting clinically significant prostate cancer: a systematic literature review","volume":"3","author":"Stabile","year":"2020","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.euo.2023.12.002_b0065","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1002\/pros.24585","article-title":"Evaluation of the optimal strategy in men with a single unilateral suspicious lesion on MRI undergoing transperineal MRI\/ultrasound fusion prostate biopsy","volume":"83","author":"Yusim","year":"2023","journal-title":"Prostate"},{"key":"10.1016\/j.euo.2023.12.002_b0070","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.urology.2016.11.017","article-title":"The role of ipsilateral and contralateral transrectal ultrasound-guided systematic prostate biopsy in men with unilateral magnetic resonance imaging lesion undergoing magnetic resonance imaging-ultrasound fusion-targeted prostate biopsy","volume":"102","author":"Bryk","year":"2017","journal-title":"Urology"},{"key":"10.1016\/j.euo.2023.12.002_b0075","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.eururo.2019.04.008","article-title":"Role of core number and location in targeted magnetic resonance imaging-ultrasound fusion prostate biopsy","volume":"76","author":"Lu","year":"2019","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2023.12.002_b0080","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1016\/j.euf.2020.06.020","article-title":"Detection of significant prostate cancer using target saturation in transperineal magnetic resonance imaging\/transrectal ultrasonography-fusion biopsy","volume":"7","author":"Tschirdewahn","year":"2021","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.euo.2023.12.002_b0085","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1097\/JU.0000000000001832","article-title":"Optimizing spatial biopsy sampling for the detection of prostate cancer","volume":"206","author":"Raman","year":"2021","journal-title":"J Urol"},{"key":"10.1016\/j.euo.2023.12.002_b0090","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.euo.2022.08.005","article-title":"Detection of clinically significant prostate cancer using targeted biopsy with four cores versus target saturation biopsy with nine cores in transperineal prostate fusion biopsy: a prospective randomized trial","volume":"6","author":"Saner","year":"2023","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.euo.2023.12.002_b0095","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1016\/j.juro.2012.01.074","article-title":"Prostate cancer foci detected on multiparametric magnetic resonance imaging are histologically distinct from those not detected","volume":"187","author":"Rosenkrantz","year":"2012","journal-title":"J Urol"},{"key":"10.1016\/j.euo.2023.12.002_b0100","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1111\/bju.14865","article-title":"Optimising the number of cores for magnetic resonance imaging-guided targeted and systematic transperineal prostate biopsy","volume":"125","author":"Hansen","year":"2020","journal-title":"BJU Int"},{"key":"10.1016\/j.euo.2023.12.002_b0105","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.eururo.2014.08.079","article-title":"Multifocality and prostate cancer detection by multiparametric magnetic resonance imaging: correlation with whole-mount histopathology","volume":"67","author":"Le","year":"2015","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2023.12.002_b0110","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.eururo.2018.11.031","article-title":"Detection of individual prostate cancer foci via multiparametric magnetic resonance imaging","volume":"75","author":"Johnson","year":"2019","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2023.12.002_b0115","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.juro.2016.07.084","article-title":"Magnetic resonance imaging underestimation of prostate cancer geometry: use of patient specific molds to correlate images with whole mount pathology","volume":"197","author":"Priester","year":"2017","journal-title":"J Urol"},{"key":"10.1016\/j.euo.2023.12.002_b0120","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/s13244-023-01450-5","article-title":"Preoperative imaging accuracy in size determination of prostate cancer in men undergoing radical prostatectomy for clinically localised disease","volume":"14","author":"Ageeli","year":"2023","journal-title":"Insights Imaging"}],"container-title":["European Urology Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2588931123002833?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2588931123002833?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,16]],"date-time":"2024-07-16T02:16:02Z","timestamp":1721096162000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2588931123002833"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":24,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["S2588931123002833"],"URL":"https:\/\/doi.org\/10.1016\/j.euo.2023.12.002","relation":{},"ISSN":["2588-9311"],"issn-type":[{"value":"2588-9311","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of Regional Saturation Biopsy, Targeted Biopsy, and Systematic Biopsy in Patients with Prostate-specific Antigen Levels of 4\u201320 ng\/ml: A Prospective, Single-center, Randomized Controlled Trial","name":"articletitle","label":"Article Title"},{"value":"European Urology Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euo.2023.12.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 European Association of Urology. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}